<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2022-09-29</publicationDate>
    
        <volume>19</volume>
        <issue>3</issue>

 
    <startPage>657</startPage>
    <endPage>670</endPage>

	 
      <doi>10.13005/bbra/3018</doi>
        <publisherRecordId>41367</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Individual and Synergistic Potential of Bioactive Compounds from Chrysopogon Zizanioides Against Main-Protease of SARS-Cov-2 using Computational Approach</title>

    <authors>
	 


      <author>
       <name>Venkataraghavan Ragunathan</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Thiruchelvi Ramakrishnan</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Rajnish Narayanan</name>

		
	<affiliationId>3</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Chemical Engineering, Alagappa College of Technology, Anna University, Chennai 600025, Tamil Nadu, India</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Bio-Engineering, School of Engineering, Vels Institute of Science Technology and Advanced Studies, Pallavaram, Chennai 600117, Tamil Nadu, India</affiliationName>
    
		
		<affiliationName affiliationId="3">Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, 603203, Tamil Nadu, India</affiliationName>
    
		
		
		
	  </affiliationsList>






    <abstract language="eng"><p style="text-align: justify;">This study presents the anti-COVID potential of bioactive compounds from <em>Chrysopogon zizanioides</em> thorough <em>in-silico</em> molecular docking approach using AutoDock Vina software. As of our knowledge, the antiviral potential of all its bioactive compounds and their synergistic potentials against SARS-CoV-2 main-protease is not reported earlier. The results were promising with β-Sitosterol (ΔG = -7.5 kcal/mol; Ki = 3.13 µM); Campesterol (ΔG = -7.4 kcal/mol; Ki = 3.71 µM); Stigmast-4-en-3-one (ΔG = -7.3 kcal/mol; Ki = 4.39 µM) forming non-covalent interactions with the amino acids in the active site of M<sup>pro</sup> causing inhibition. The synergistic potential of compounds showed a significant sign of inhibition against M<sup>pro </sup>with -7.9 kcal/mol with the sequential combination of β-Sitosterol; Campesterol; Stigmast-4-en-3-one. The docking protocol validation was performed by re-docking and superimposing co-crystallized ligand, and interactions visualized using Discovery Studio 2020. Moreover, all the compounds satisfied Lipinski’s oral drug-likeliness properties to be used and oral drug. These bioactive compounds of <em>Chrysopogon zizanioides</em> showed low binding energies against SARS-CoV-2 M<sup>pro</sup> which proved their anti-COVID potential. Thus, by incorporating <em>Chrysopogon zizanioides</em> for consumption in daily life, it is very likely that one can get rid of COVID-19.</p></abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol19no3/individual-and-synergistic-potential-of-bioactive-compounds-from-chrysopogon-zizanioides-against-main-protease-of-sars-cov-2-using-computational-approach/</fullTextUrl>



      <keywords language="eng">
        <keyword>AutoDock Vina; <em>Chrysopogon zizanioides</em>; COVID-19; Main-protease; SARS-CoV-2</keyword>
      </keywords>

  </record>
</records>